Trial Profile
A Placebo-Controlled, Randomized, Double-Blind, Parallel-Group, Dose-Finding Trial to Evaluate the Efficacy and Safety of TBS-2 Intranasal Testosterone Gel in Women With Acquired Female Orgasmic Disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Aug 2018
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Anorgasmia
- Focus Therapeutic Use
- Acronyms AMB
- Sponsors Acerus Pharmaceuticals; Trimel Pharmaceuticals Corporation
- 16 Oct 2017 Trimel Pharmaceuticals Corporation changed it's name to Acerus Pharmaceuticals Corporation on 9 September 2015.
- 16 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Jul 2014 Top-line results published in a Trimel Pharmaceuticals media release.